Dividend compounder review

AGY

Allergy Therapeutics plc · LSE · GB

Healthcare · Drug Manufacturers - Specialty & Generic

Chart Factor Intelligence Back to Screener
Score21.50/100
Confidence78.00/100
DecisionInsufficient Data
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 0.0 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 7.0 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 9.5 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 1.0 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 4.0 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income£-40.1M
Free Cash Flow£-31.5M
FCF Covers DividendUnknown
Debt / Equity6.30
P/E-
Revenue Growth 5Y-8.9%
Net Margin-84.1%
ROE-9.4%
Price vs Trend-25.4%
3Y Return652.4%
5Y Return-68.4%
CurrencyGBP
Warnings

Review flags

No usable dividend history found.
Free cash flow is negative.
Debt to equity is elevated at 6.30.
Dividend diary

Activity record

AGY dividend review warning Warning · Warning

Debt to equity is elevated at 6.30.